Navigation Links
North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year
Date:5/22/2008

ss. Prior portfolio company holdings include Equinox Fitness, EAS, CRC Health Group, Doctor's Dermatologic Formula, Naked Juice Company and Avalon Natural Products.

North Castle is led by a seasoned investment team including 15 proactive operating advisors who bring a wide range of operational and investment capabilities as well as an extensive knowledge base and network. The strength of the North Castle team, combined with our focus and network, provides significant competitive advantages in building world-class companies. North Castle is headquartered in Greenwich, CT. For more information, visit http://www.northcastlepartners.com.

Contact: Todd Fogarty

Kekst and Company

212-521-4854

todd-fogarty@kekst.com


'/>"/>
SOURCE North Castle Partners
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novo Nordisk Appoints New Leader of North American Business
2. Health IT Event Draws Experts to the Pacific Northwest
3. Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABCs 20/20, National Geographic Channel
4. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
5. Evanston Northwestern Healthcare Wins Award For Patient Safety
6. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
7. Northstar Healthcare Announces Option to Purchase a 60% Interest in The Palladium for Surgery - Dallas
8. Dermatologists identify North Texas leishmaniasis outbreak
9. Radiation Therapy Services Acquires North Carolina Facility
10. Northern Michigan Regional Health System Named a Working Mother 100 Best Company - 2007 by Working Mother Magazine
11. NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ALLAS, Jan. 8 A study released thi...are suffering from multiple chronic diseases shine... U.S. health care system to one that focuses on pr...Preventive Medicine, the leader in disease prevent...bin/prnh/20080506/NETU129LOGO ) , , The study...
(Date:1/8/2009)...enator Dole introduces Senator Daschle at his conf...h and Human Services , , , WASHINGTON, Jan. 8...er (BPC) founding board member Senator Tom Daschle...ces Secretary, was introduced by fellow BPC founde...hearing today. The hearing was convened by the Sen...
(Date:1/8/2009)...entists at St. Jude Children,s Research Hospital h...cterial pneumonia following influenza. They found ... which kill bacteria by inhibiting their protein s...-line treatment with the "beta-lactam" antibiotic ...burst. , The finding is important because pneu...
(Date:1/8/2009)... SAN FRANCISCO, Jan. 8 ...ed that David Hung, M.D., president and chief,exe...P. Morgan Healthcare,Conference on Wednesday, Jan...,St. Francis Hotel in San Francisco. , Dr. ...s clinical,development programs for Dimebon for A...
Breaking Medicine News(10 mins):Health News:U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
... drug fondaparinux (Arixta) nearly halves the risk...lmonary embolism in people hospitalized with conge...nd other conditions that increase the risk of thes...treated with the drug were 47 percent less likely ...
...king the herbal extract black cohosh is an effecti...w research shows the supplement may not be safe fo...ected breast tumors. Researchers from the Mylan Sc...udied how the herbal treatment affected female mic...
..., food allergy -- especially to peanuts -- has bee...thma in children. Asthma attacks are the most comm... Graham Roberts from St. Mary's Hospital in London...des in treatment, death due to childhood asthma ha...
...fatigue may reduce anxiety and depression in cance...s say fatigue may be improved or reversed with the...tudy were anemic patients undergoing chemotherapy ... Aranesp at a starting dose of 2.25 micrograms or ...
Other Medicine News:
(Date:1/7/2009)...re-USNewswire/ -- Scientists have identified mutat...elapse in children with acute lymphoblastic leukem...rther research is needed to determine how changes ...eukemia relapse, the findings are likely to provid...the risk of treatment failure. By using a molecula...
(Date:1/7/2009)...PRNewswire/ -- Circassia Ltd, a specialty,biophar... care, today,announced that following successful ...Mune(R) anti-allergy technology, the company has n...ase II clinical trial in cat allergy. The,study, ...ients with confirmed,cat allergies, and all the p...
(Date:1/6/2009)...re-USNewswire/ -- Sequella, Inc., a clinical-stage...epidemic potential, announced today that SQ109, it...losis (TB), was the first drug approved for evalua...to Dynport Vaccine Company LLC and Quintiles Trans...stitute of Allergy and Infectious Diseases (NIAID)...
(Date:1/5/2009)...swire-FirstCall/ -- Micromet, Inc.,(Nasdaq: MIT... proprietary,antibodies for the treatment of canc...s an outlook on key events anticipated for the yea...update on its research and development,programs a..., 2009: Update on several preclinical BiTE antibod...
Breaking Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5BEING DAD DVD Offers a Sneak Peek at Pregnancy From a Guys Point of View 27074 1BEING DAD DVD Offers a Sneak Peek at Pregnancy From a Guys Point of View 27074 2Novel imaging approach may assist in predicting success of treatment for atrial fibrillation 27072 1Novel imaging approach may assist in predicting success of treatment for atrial fibrillation 27072 2Often Disenfranchised People With Mental Disabilities Can Assert Their Voting Rights 27069 1Often Disenfranchised People With Mental Disabilities Can Assert Their Voting Rights 27069 2BOOMj Inc Joins Fight Against Breast Cancer 27065 1BOOMj Inc Joins Fight Against Breast Cancer 27065 2BOOMj Inc Joins Fight Against Breast Cancer 27065 3
...- Ceragenix Pharmaceuticals,Inc. (OTCBB:CGXP), a ...sease and dermatology, today announced the publica...ntimicrobial,compounds: CSA-8 and CSA-13. The pape...timicrobial Agents and Chemotherapy, a,peer-review...robiology, dedicated to advances in the field of a...
... 2007 - Affitech AS, the,human antibody therapeuti...uticals, Inc. reported positive in vivo test resul...ped by Affitech, in a,pancreatic cancer model at t... the American Association for Cancer Research (AAC...selective blocking of,VEGF (vascular endothelial g...
Other Medicine Technology:Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 2Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 3Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 4Positive Results Using Affitech-Identified Human Antibody That,Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model,Reported by Peregrine 2
...he Alcon OcuScan RxP Ophthalmic Ultrasound System,...nd instrumentation. With improved auto modes and f...e to obtain measurements that are both accurate an...y providing high quality eye measurements in an ea...
...ted a new generation locking nail system, bringing...arate nailing systems to create a single, integrat...ctures. , ,Through the development of a common, s...n principle and in detail, the T2&trade Tibial Nai...
...el in yield strength, and 25% higher in ultimate t...allow for easy insertion, increased strength, and ... combined mechanical properties of high strength a... Nail to offer a potential reduction of implant fa...
The Elite™ Premium Shoulder Instrument Systems offer the surgeon comprehensive flexibility in arthroscopic and mini-open shoulder repairs, such as rotator cuff and Bankart repair. Smith & Nephe
Medicine Products: